Merck And Co Sustainability Profile
Merck & Co., Inc., commonly referred to as Merck, is a leading global healthcare company headquartered in the United States. Founded in 1891, Merck has established itself as a pioneer in the pharmaceutical industry, focusing on innovative medicines, vaccines, and biologic therapies. With a strong presence in North America, Europe, and Asia, the company is dedicated to improving health outcomes worldwide. Merck's core products include groundbreaking treatments in oncology, infectious diseases, and vaccines, notably the HPV vaccine Gardasil and the cancer immunotherapy Keytruda. These offerings are distinguished by their commitment to research and development, which has led to numerous key milestones in medical advancements. As a market leader, Merck consistently ranks among the top pharmaceutical companies globally, recognised for its contributions to public health and its robust pipeline of future therapies.
DitchCarbon Score
How does Merck And Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merck And Co's score of 91 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merck And Co's reported carbon emissions
In 2024, Merck & Co., headquartered in the US, reported total greenhouse gas emissions of approximately 1,256,000,000 kg CO2e. This figure includes 146,000,000 kg CO2e from Scope 1 emissions, 100,000,000 kg CO2e from Scope 2 emissions, and a significant 1,110,000,000 kg CO2e from Scope 3 emissions. In comparison, the 2023 emissions were slightly higher, with total emissions of about 1,380,000,000 kg CO2e, comprising 150,000,000 kg CO2e (Scope 1), 110,000,000 kg CO2e (Scope 2), and 1,200,000,000 kg CO2e (Scope 3). Merck has set ambitious climate commitments, aiming to reduce its operational greenhouse gas emissions (Scopes 1 and 2) by 46% by 2030, using a 2019 baseline. Additionally, the company is committed to achieving carbon neutrality across its operations by 2025. For Scope 3 emissions, Merck targets a reduction of 30% by 2030. Long-term, the company aims for net-zero emissions across all scopes by 2045, with a 90% reduction target for absolute emissions from all scopes by the same year. These targets align with the Science Based Targets initiative (SBTi) guidelines, demonstrating Merck's commitment to addressing climate change and reducing its carbon footprint in the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,532,400,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 5,760,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Merck And Co's Industry?
How Carbon Intensive is Merck And Co's Location?
Merck And Co's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merck And Co has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Thermo Fisher Scientific
GlaxoSmithKline Pharmaceuticals Limited
Frequently Asked Questions
Common questions about Merck And Co's sustainability data and climate commitments